Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682992 · ClinicalTrials.gov registry record · NA
Low-Level Laser Therapy for Prevention of Oral Mucositis
A NA study, sponsored by David A. Clump, MD, PhD.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02682992 is a NA study that has completed, run by David A. Clump, MD, PhD. The registered enrollment target is 47 participants.
The verdict
NCT02682992, a NA study, has completed, sponsored by David A. Clump, MD, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The overall purpose of this study is to examine the efficacy of prophylactic low-level laser therapy (LLLT) to reduce the incidence of oral mucositis and adverse events in patients receiving combined modality therapy consisting of chemotherapy and radiation therapy for head and neck cancer.
Interventions
- DEVICE Low Level Laser Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682992
The ClinicalTrials.gov registry entry for NCT02682992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David A. Clump, MD, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low Level Laser Therapy is the first listed.
NCT02682992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02682992 about?
NCT02682992 is a clinical study titled "Low-Level Laser Therapy for Prevention of Oral Mucositis". The overall purpose of this study is to examine the efficacy of prophylactic low-level laser therapy (LLLT) to reduce the incidence of oral mucositis and adverse events in patients receiving combined modality therapy consisting of chemotherapy and radiation therapy for head and neck cancer.
What is the current status of trial NCT02682992?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2016-06. Estimated completion is 2020-11.
What interventions are being tested in trial NCT02682992?
The interventions under investigation include: Low Level Laser Therapy (DEVICE).
Who is sponsoring clinical trial NCT02682992?
This trial is sponsored by David A. Clump, MD, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.